Latest news
Capricor (CAPR) Securities Investigation Notice - Levi & Korsinsky - MorningstarMorningstar · Wed, 05 Aug 2026 19:09:00 GMTCapricor seeks court intervention in fight over DMD cell therapy launch - FirstWord PharmaFirstWord Pharma · Wed, 05 Aug 2026 07:00:00 GMTCAPR Stock Drop: Capricor Therapeutics Clinical Data Leads to 64% Stock Drop and Securities Fraud Class Action for Investors - TradingViewTradingView · Tue, 04 Aug 2026 10:36:00 GMTFDA Panel Votes Against Deramiocel for DMD Cardiomyopathy - Endocrinology AdvisorEndocrinology Advisor · Mon, 03 Aug 2026 04:00:00 GMTStockWatch: Capricor Plunges as FDA Panel, Staff Question Effectiveness of Lead Candidate Deramiocel - Genetic Engineering and Biotechnology NewsGenetic Engineering and Biotechnology News · Mon, 03 Aug 2026 00:49:26 GMTCAPR Stock On Track For Worst Week Ever After Regulatory Setback For DMD Therapy - TradingViewTradingView · Fri, 31 Jul 2026 17:42:39 GMTFDA advisory panel votes against Capricor's Duchenne cell therapy deramiocel - DealroomDealroom · Thu, 30 Jul 2026 22:39:44 GMTCapricor Therapeutics: FDA Advisory Panel Votes 9-3 That Evidence Does Not Support Deramiocel for DMD Cardiomyopathy - TradingViewTradingView · Thu, 30 Jul 2026 20:13:04 GMT